Hold Dr Reddy’s Laboratories; target of Rs 1270: ICICI Securities
Dr. Reddy’s Laboratories’ (DRL ... US sales posted growth of 15.6% YoY to USD 445mn, likely driven by gRevlimid (pegged at ...
DRL Q2 net falls 15% despite revenue surge
HYDERABAD: Pharma major Dr Reddy's Laboratories on Tuesday reported a 15% drop in ... Consolidated net profit for Q2 fell to ...
Q2 results today: Tata Steel, Apollo, JK Lakshmi among 97 to post earning
ALSO READ: Dr Reddy's clocks highest-ever revenue in Q2; net profit down 9.5% Meanwhile, Delhi-based Mankind Pharma reported ...
Sensex, Nifty open higher as markets eye US election results, Fed meet
Dr Reddy’s Lab led the gainers on NSE ... However, he cautioned that “poor earnings growth in Q2 and earnings downgrades for ...
Dr Reddy's Labs shares in focus after Q2 profit falls 15% YoY. What should investors do?
Dr. Reddy's Labs reported a 15% decline in Q2 net profit, despite a 17% rise in revenue driven by global generics. While ...
ndtvprofit5h
Dr. Reddy's Q2 Results Review: Brokerages Maintain Cautious Stance As US Challenges Loom
Dr. Reddy's' US sales continued to struggle due to inventory adjustments and pricing pressures on key products, Citi said.
ndtvprofit5h
Dr. Reddy’s Q2 Results Review - Performance Inline With Expectations; Upgrade To 'Hold': Systematix
The brokerage expects the new business avenues to take a few years before they start contributing profitably to the ...
Business Insider5h
Dr. Reddy’s Reports Strong Q2FY25 Results and Strategic Expansions
Dr. Reddy’s Laboratories Ltd ( (RDY)) has released its Q2 earnings. Here is a breakdown of the information Dr. Reddy’s Laboratories Ltd presented to its investors. Dr. Reddy’s Laboratories Ltd., a ...
Dr Reddy's Q2 performance sees revenue boost, but challenges persist
Dr Reddy’s Laboratories posted a mixed performance in Q2FY25, reporting record revenue of Rs 8,038.2 crore, marking a strong ...
cnbctv185h
Dr. Reddy's analysts remain cautious citing lack of near-term catalysts post Q2
Shares of Dr. Reddy's Laboratories Ltd. will be closely watched in Wednesday's trading as its revenue for the September ...
Dr Reddy’s clocks 16.51% increase in Q2 revenues
New Delhi: Pharma major Dr Reddy’s Laboratories (DRL ... Its total operating expenses grew 34.3 per cent to Rs3,021.8 crore ...
Deccan Chronicle7h
Pharma Sees Better Revenue Growth in Q2
Chennai: Pharma market reported better revenue growth in Q2 FY25 against the year-ago quarter, mainly driven by price rise ...